Boston Scientific stockholders approve charter amendments and ESPP share increase at 2026 annual meeting

approved amendments (the “Charter Amendments”) to the Company’s Third Restated Certificate of Incorporation, as described in the Company’s definitive proxy statement for the Annual Meeting filed on March 18, 2026 (the “Proxy Statement”) to (a) eliminate supermajority voting provisions contained therein, as well as to eliminate certain inoperative provisions and implement other clarifying and correcting changes, and (b) provide for exculpation of certain of our officers in certain circumstances as permitted by Delaware law. The Charter Amendments became effective upon the filing of the Company’s Fourth Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on May 5, 2026.

(3) The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. For Against Abstain Broker Non-Votes 1,169,955,769 116,874,243 4,835,910 0

(5) The stockholders approved the amendment of the Company’s Third Restated Certificate of Incorporation to remove supermajority voting provisions. For Against Abstain Broker Non-Votes 1,189,271,431 17,774,053 3,348,909 81,271,529

(6) The stockholders approved the amendment of the Company’s Third Restated Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law. For Against Abstain Broker Non-Votes 1,057,086,923 150,458,633 2,848,837 81,271,529

(4) The stockholders approved the amendment of the Company’s Employee Stock Purchase Plan to increase the number of shares reserved for issuance. For Against Abstain Broker Non-Votes 1,205,130,032 2,818,667 2,445,694 81,271,529

(1) All 10 director nominees were elected to the Board for a one-year term, to hold office until the Company’s 2027 Annual Meeting of Stockholders and until their successors have been elected and qualified. Nominee For Against Abstain Broker Non-Votes David C. Habiger 1,037,805,652 169,730,106 2,858,635 81,271,529 Edward J. Ludwig 1,156,469,560 50,835,636 3,089,197 81,271,529 Michael F. Mahoney 1,113,612,016 93,613,027 3,169,350 81,271,529 Jessica L. Mega 1,196,020,676 11,532,045 2,841,672 81,271,529 Susan E. Morano 1,171,890,417 35,662,932 1,841,044 81,271,529 Cheryl Pegus 1,195,889,562 11,653,832 2,850,999 81,271,529 Cathy R. Smith 1,117,908,896 88,044,911 4,440,586 81,271,529 Christophe P. Weber 1,205,365,637 2,260,256 2,768,500 81,271,529 David S. Wichmann 1,198,736,185 8,393,038 3,265,170 81,271,529 Ellen M. Zane 1,150,092,668 56,753,553 3,548,172 81,271,529

(7) The stockholders did not approve the amendment of the Company’s Third Restated Certificate of Incorporation and Amended and Restated By-Laws to permit stockholders owning not less than 25% of the Company’s common stock to call a special meeting of stockholders. For Against Abstain Broker Non-Votes 1,095,371,430 20,945,183 94,077,780 81,271,529

(2) The stockholders approved, on an advisory basis, the compensation of the Company’s “Named Executive Officers” as disclosed in the Company’s proxy statement for the Annual Meeting. For Against Abstain Broker Non-Votes 1,096,889,576 110,645,813 2,859,004 81,271,529

(8) The stockholders did not approve the stockholder proposal titled “Give Shareholders the Ability to Call for a Special Shareholder Meeting.” For Against Abstain Broker Non-Votes 516,140,863 689,739,605 4,513,925 81,271,529